Berberine Ameliorates Hepatic Steatosis and Suppresses Liver and Adipose Tissue Inflammation in Mice with Diet-induced Obesity

Ting Guo, Shih Lung Woo, Xin Guo, Honggui Li, Juan Zheng, Rachel Botchlett, Mengyang Liu, Ya Pei, Hang Xu, Yuli Cai, Tianshu Zeng, Lulu Chen, Xiaodong Li, Qifu Li, Xiaoqiu Xiao, Yuqing Huo, Chaodong Wu

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Increasing evidence demonstrates that berberine (BBR) is beneficial for obesity-associated non-alcoholic fatty liver disease (NAFLD). However, it remains to be elucidated how BBR improves aspects of NAFLD. Here we revealed an AMP-activated protein kinase (AMPK)-independent mechanism for BBR to suppress obesity-associated inflammation and improve hepatic steatosis. In C57BL/6J mice fed a high-fat diet (HFD), treatment with BBR decreased inflammation in both the liver and adipose tissue as indicated by reduction of the phosphorylation state of JNK1 and the mRNA levels of proinflammatory cytokines. BBR treatment also decreased hepatic steatosis, as well as the expression of acetyl-CoA carboxylase and fatty acid synthase. Interestingly, treatment with BBR did not significantly alter the phosphorylation state of AMPK in both the liver and adipose tissue of HFD-fed mice. Consistently, BBR treatment significantly decreased the phosphorylation state of JNK1 in both hepatoma H4IIE cells and mouse primary hepatocytes in both dose-dependent and time-dependent manners, which was independent of AMPK phosphorylation. BBR treatment also caused a decrease in palmitate-induced fat deposition in primary mouse hepatocytes. Taken together, these results suggest that BBR actions on improving aspects of NAFLD are largely attributable to BBR suppression of inflammation, which is independent of AMPK.

Original languageEnglish (US)
Article number22612
JournalScientific Reports
Volume6
DOIs
StatePublished - Mar 3 2016

Fingerprint

Berberine
Fatty Liver
Adipose Tissue
Obesity
Diet
Inflammation
Liver
AMP-Activated Protein Kinases
Phosphorylation
High Fat Diet
Hepatocytes
Acetyl-CoA Carboxylase
Fatty Acid Synthases
Palmitates
Inbred C57BL Mouse
Hepatocellular Carcinoma
Fats
Cytokines

ASJC Scopus subject areas

  • General

Cite this

Berberine Ameliorates Hepatic Steatosis and Suppresses Liver and Adipose Tissue Inflammation in Mice with Diet-induced Obesity. / Guo, Ting; Woo, Shih Lung; Guo, Xin; Li, Honggui; Zheng, Juan; Botchlett, Rachel; Liu, Mengyang; Pei, Ya; Xu, Hang; Cai, Yuli; Zeng, Tianshu; Chen, Lulu; Li, Xiaodong; Li, Qifu; Xiao, Xiaoqiu; Huo, Yuqing; Wu, Chaodong.

In: Scientific Reports, Vol. 6, 22612, 03.03.2016.

Research output: Contribution to journalArticle

Guo, T, Woo, SL, Guo, X, Li, H, Zheng, J, Botchlett, R, Liu, M, Pei, Y, Xu, H, Cai, Y, Zeng, T, Chen, L, Li, X, Li, Q, Xiao, X, Huo, Y & Wu, C 2016, 'Berberine Ameliorates Hepatic Steatosis and Suppresses Liver and Adipose Tissue Inflammation in Mice with Diet-induced Obesity', Scientific Reports, vol. 6, 22612. https://doi.org/10.1038/srep22612
Guo, Ting ; Woo, Shih Lung ; Guo, Xin ; Li, Honggui ; Zheng, Juan ; Botchlett, Rachel ; Liu, Mengyang ; Pei, Ya ; Xu, Hang ; Cai, Yuli ; Zeng, Tianshu ; Chen, Lulu ; Li, Xiaodong ; Li, Qifu ; Xiao, Xiaoqiu ; Huo, Yuqing ; Wu, Chaodong. / Berberine Ameliorates Hepatic Steatosis and Suppresses Liver and Adipose Tissue Inflammation in Mice with Diet-induced Obesity. In: Scientific Reports. 2016 ; Vol. 6.
@article{eaae2429708b4fb58d86c7d7fb54bc5c,
title = "Berberine Ameliorates Hepatic Steatosis and Suppresses Liver and Adipose Tissue Inflammation in Mice with Diet-induced Obesity",
abstract = "Increasing evidence demonstrates that berberine (BBR) is beneficial for obesity-associated non-alcoholic fatty liver disease (NAFLD). However, it remains to be elucidated how BBR improves aspects of NAFLD. Here we revealed an AMP-activated protein kinase (AMPK)-independent mechanism for BBR to suppress obesity-associated inflammation and improve hepatic steatosis. In C57BL/6J mice fed a high-fat diet (HFD), treatment with BBR decreased inflammation in both the liver and adipose tissue as indicated by reduction of the phosphorylation state of JNK1 and the mRNA levels of proinflammatory cytokines. BBR treatment also decreased hepatic steatosis, as well as the expression of acetyl-CoA carboxylase and fatty acid synthase. Interestingly, treatment with BBR did not significantly alter the phosphorylation state of AMPK in both the liver and adipose tissue of HFD-fed mice. Consistently, BBR treatment significantly decreased the phosphorylation state of JNK1 in both hepatoma H4IIE cells and mouse primary hepatocytes in both dose-dependent and time-dependent manners, which was independent of AMPK phosphorylation. BBR treatment also caused a decrease in palmitate-induced fat deposition in primary mouse hepatocytes. Taken together, these results suggest that BBR actions on improving aspects of NAFLD are largely attributable to BBR suppression of inflammation, which is independent of AMPK.",
author = "Ting Guo and Woo, {Shih Lung} and Xin Guo and Honggui Li and Juan Zheng and Rachel Botchlett and Mengyang Liu and Ya Pei and Hang Xu and Yuli Cai and Tianshu Zeng and Lulu Chen and Xiaodong Li and Qifu Li and Xiaoqiu Xiao and Yuqing Huo and Chaodong Wu",
year = "2016",
month = "3",
day = "3",
doi = "10.1038/srep22612",
language = "English (US)",
volume = "6",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Berberine Ameliorates Hepatic Steatosis and Suppresses Liver and Adipose Tissue Inflammation in Mice with Diet-induced Obesity

AU - Guo, Ting

AU - Woo, Shih Lung

AU - Guo, Xin

AU - Li, Honggui

AU - Zheng, Juan

AU - Botchlett, Rachel

AU - Liu, Mengyang

AU - Pei, Ya

AU - Xu, Hang

AU - Cai, Yuli

AU - Zeng, Tianshu

AU - Chen, Lulu

AU - Li, Xiaodong

AU - Li, Qifu

AU - Xiao, Xiaoqiu

AU - Huo, Yuqing

AU - Wu, Chaodong

PY - 2016/3/3

Y1 - 2016/3/3

N2 - Increasing evidence demonstrates that berberine (BBR) is beneficial for obesity-associated non-alcoholic fatty liver disease (NAFLD). However, it remains to be elucidated how BBR improves aspects of NAFLD. Here we revealed an AMP-activated protein kinase (AMPK)-independent mechanism for BBR to suppress obesity-associated inflammation and improve hepatic steatosis. In C57BL/6J mice fed a high-fat diet (HFD), treatment with BBR decreased inflammation in both the liver and adipose tissue as indicated by reduction of the phosphorylation state of JNK1 and the mRNA levels of proinflammatory cytokines. BBR treatment also decreased hepatic steatosis, as well as the expression of acetyl-CoA carboxylase and fatty acid synthase. Interestingly, treatment with BBR did not significantly alter the phosphorylation state of AMPK in both the liver and adipose tissue of HFD-fed mice. Consistently, BBR treatment significantly decreased the phosphorylation state of JNK1 in both hepatoma H4IIE cells and mouse primary hepatocytes in both dose-dependent and time-dependent manners, which was independent of AMPK phosphorylation. BBR treatment also caused a decrease in palmitate-induced fat deposition in primary mouse hepatocytes. Taken together, these results suggest that BBR actions on improving aspects of NAFLD are largely attributable to BBR suppression of inflammation, which is independent of AMPK.

AB - Increasing evidence demonstrates that berberine (BBR) is beneficial for obesity-associated non-alcoholic fatty liver disease (NAFLD). However, it remains to be elucidated how BBR improves aspects of NAFLD. Here we revealed an AMP-activated protein kinase (AMPK)-independent mechanism for BBR to suppress obesity-associated inflammation and improve hepatic steatosis. In C57BL/6J mice fed a high-fat diet (HFD), treatment with BBR decreased inflammation in both the liver and adipose tissue as indicated by reduction of the phosphorylation state of JNK1 and the mRNA levels of proinflammatory cytokines. BBR treatment also decreased hepatic steatosis, as well as the expression of acetyl-CoA carboxylase and fatty acid synthase. Interestingly, treatment with BBR did not significantly alter the phosphorylation state of AMPK in both the liver and adipose tissue of HFD-fed mice. Consistently, BBR treatment significantly decreased the phosphorylation state of JNK1 in both hepatoma H4IIE cells and mouse primary hepatocytes in both dose-dependent and time-dependent manners, which was independent of AMPK phosphorylation. BBR treatment also caused a decrease in palmitate-induced fat deposition in primary mouse hepatocytes. Taken together, these results suggest that BBR actions on improving aspects of NAFLD are largely attributable to BBR suppression of inflammation, which is independent of AMPK.

UR - http://www.scopus.com/inward/record.url?scp=84960153111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960153111&partnerID=8YFLogxK

U2 - 10.1038/srep22612

DO - 10.1038/srep22612

M3 - Article

VL - 6

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 22612

ER -